Form4.ai tracks every SEC insider trade in real time. See every XENE insider filing with a free account — no card.
See every XENE insider filing — free account, no card.
Free accountXenon Pharmaceuticals Inc. (XENE) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $1.7M, and 2 sales totalling $1.1M. Most recent filing: Oct. 16, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 16, 2026 SEC filing | Kelly Thomas Patrick Chief Financial Officer | Option exercise | — | — |
| Oct 1, 2026 SEC filing | Kelly Thomas Patrick Chief Financial Officer | Bought | $559,740 | +0.6% 30D |
| Oct 1, 2026 SEC filing | MORTIMER IAN PRESIDENT & CEO | Bought | $1,121,400 | +0.4% 30D |
Create a free account to see all 6 XENE filings from the last 90 days. No card needed.
Create free accountWant XENE insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.